Healthcare
By
Can AstraZeneca’s $50 Billion U.S. Investment and Drug Price Cuts Signal a New Era of Affordable Innovation and Domestic Manufacturing?
Key Highlights: Strategic Response to U.S. Pricing PressuresAstraZeneca CEO Pascal Soriot announced proactive proposals for U.S. drug price…
How Google Med-Gemini’s “Basilar Ganglia” AI Hallucination Signal a Wake-Up Call for Safer AI in Medical Diagnostics?
Key Highlights: AI Hallucination: The “Basilar Ganglia” ErrorGoogle’s Med-Gemini suite, designed to summarize health data and generate radiology…
Will CMS’s 2026 WISeR AI Pilot Shift Traditional Medicare’s Access—How Might Algorithmic Prior Authorizations Reshape Patient Outcomes for 30 Million Seniors?
Key Highlights: AI-Powered Prior Authorization: New Model and ScopeCMS’s WISeR (Wasteful and Inappropriate Service Reduction) program introduces AI…
Can Harvard’s FaceAge and Emerging AI Facial Recognition Apps Revolutionize Disease Prediction and Personalized Care in Biopharma and Healthcare?
Key Highlights: AI Facial Recognition as a Medical BiomarkerDeveloped at Harvard Medical School, the FaceAge algorithm analyzes photos…
Can Novo Nordisk’s New Semaglutide and Obesity Pipeline Data at EASD 2025 Redefine ‘Food Noise’ Control, Body Composition, and Cardiovascular Outcomes?
Key Highlights: Scientific Momentum at EASD 2025Novo Nordisk will present 35 abstracts across its diabetes and obesity portfolio…
Could GE HealthCare’s FDA-Cleared Revolution™ Vibe CT System Usher in a New Era of AI-Powered Cardiac Imaging?
Key Highlights Revolutionizing Cardiac Imaging with One-Beat ClarityGE HealthCare’s Revolution Vibe CT system has received U.S. FDA 510(k)…
